Author： Vries P.D. Villalón C.M. Saxena P.R.
Publisher： Informa Healthcare
ISSN： 1472-8214
Source： Expert Opinion on Emerging Drugs, Vol.4, Iss.1, 1999-01, pp. : 107-125
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Triptans in Migraine: A Comparative Review of Pharmacology, Pharmacokinetics and Efficacy
Drugs, Vol. 60, Iss. 6, 2000-12 ,pp. :
Access to resources
Recommend
By Tepper S.J.
CNS Drugs, Vol. 12, Iss. 5, 1999-11 ,pp. :
Tolerability of the Triptans: Clinical Implications
By Nappi G.
Drug Safety, Vol. 26, Iss. 2, 2003-01 ,pp. :
The Use of Triptans for Pediatric Migraines
Pediatric Drugs, Vol. 12, Iss. 6, 2010-12 ,pp. :
Triptans for the Management of Migraine
By Johnston Mollie M. Rapoport Alan M.
Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. :